5N,6S- (N'- butyliminomethylidene)- 6- thio- 1- deoxygalactonojirimycin

a pharmacological chaperone for lysosomal beta-galactosidase; structure in first source

Also Known As:

6S-NBI-DGJ

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Aguilar-Moncayo, Matilde: 1 article (03/2013)
2.	García Fernández, José M: 1 article (03/2013)
3.	García-Moreno, M Isabel: 1 article (03/2013)
4.	Higaki, Katsumi: 1 article (03/2013)
5.	Hirano, Yuki: 1 article (03/2013)
6.	Mena-Barragán, Teresa: 1 article (03/2013)
7.	Nanba, Eiji: 1 article (03/2013)
8.	Ninomiya, Haruaki: 1 article (03/2013)
9.	Ohno, Kousaku: 1 article (03/2013)
10.	Ortiz Mellet, Carmen: 1 article (03/2013)

1.	GM1 Gangliosidosis (Gangliosidosis GM1) 03/01/2013 - "Finally, oral administration of 6S-NBI-DGJ ameliorated the brain pathology of GM1 gangliosidosis model mice. "

1.	Oral Administration